0,882  0,003  Caspase 3 stimulant
0,805  0,004  5 Hydroxytryptamine release stimulant
0,804  0,004  Antineoplastic (brain cancer)
0,803  0,004  Antineoplastic (glioma)
0,801  0,008  Antineoplastic (lung cancer)
0,784  0,019  Apoptosis agonist
0,775  0,015  Caspase 9 stimulant
0,757  0,013  Antineoplastic (breast cancer)
0,720  0,005  Antimitotic
0,725  0,012  Antineoplastic (colon cancer)
0,725  0,012  Antineoplastic (colorectal cancer)
0,707  0,006  NOS2 expression inhibitor
0,686  0,014  Antileukemic
0,675  0,005  CYP2C19 inhibitor
0,673  0,012  Prostate cancer treatment
0,641  0,002  Carcinogenic, group 2A
0,639  0,003  ICAM1 expression inhibitor
0,651  0,016  Alzheimer's disease treatment
0,635  0,014  Antihypercholesterolemic
0,627  0,008  Cardioprotectant
0,617  0,004  Topoisomerase II inhibitor
0,615  0,022  15-Lipoxygenase inhibitor
0,594  0,006  Antineoplastic (glioblastoma multiforme)
0,633  0,045  Antiinflammatory
0,588  0,010  Nitric oxide antagonist
0,588  0,012  Antioxidant
0,566  0,004  Diabetic nephropathy treatment
0,573  0,018  Antineoplastic (ovarian cancer)
0,565  0,014  Hepatic disorders treatment
0,572  0,023  Antiparkinsonian
0,554  0,008  Vasodilator
0,562  0,017  Antineoplastic (melanoma)
0,578  0,034  Transcription factor NF kappa B inhibitor
0,536  0,006  Hepatoprotectant
0,541  0,013  Antiprotozoal (Leishmania)
0,535  0,009  Antineoplastic (lymphoma)
0,526  0,005  Cyclic AMP phosphodiesterase inhibitor
0,511  0,004  Carcinogenic, group 1
0,510  0,009  Antineoplastic (renal cancer)
0,492  0,004  Neurotrophic factor enhancer
0,492  0,004  Topoisomerase I inhibitor
0,483  0,005  VCAM1 expression inhibitor
0,505  0,027  Histamine release inhibitor
0,489  0,013  CYP3A4 inhibitor
0,491  0,020  Chemopreventive
0,494  0,023  Sensitization
0,493  0,026  CYP2C9 inhibitor
0,482  0,017  Antipyretic
0,470  0,008  Antineoplastic (squamous cell carcinoma)
0,510  0,050  Antineoplastic (solid tumors)
0,474  0,025  Antineoplastic (cervical cancer)
0,465  0,022  Antineoplastic (non-small cell lung cancer)
0,450  0,016  Psychostimulant
0,440  0,009  Genotoxic
0,447  0,027  Cytostatic
0,454  0,039  Mood disorders treatment
0,451  0,036  Respiratory analeptic
0,445  0,037  Antidepressant
0,433  0,032  Antiischemic
0,424  0,028  Antineoplastic (multiple myeloma)
0,398  0,004  Histone deacetylase SIRT1 stimulant
0,398  0,004  Histone deacetylase stimulant
0,392  0,004  Estrogen agonist
0,421  0,034  Antihypertensive
0,400  0,015  Muscle relaxant
0,414  0,031  Vasodilator, coronary
0,417  0,034  Antineoplastic (pancreatic cancer)
0,409  0,027  DNA damaging
0,388  0,010  Skeletal muscle relaxant
0,403  0,028  Free radical scavenger
0,388  0,014  Antineoplastic (carcinoma)
0,389  0,017  Antiparkinsonian, rigidity relieving
0,405  0,037  Apoptosis antagonist
0,389  0,022  Antineoplastic (small cell lung cancer)
0,378  0,013  Tubulin antagonist
0,372  0,010  Acaricide
0,375  0,014  Melanin inhibitor
0,454  0,094  Alpha-glucosidase inhibitor
0,369  0,012  Pneumotoxic
0,408  0,053  Vasodilator, peripheral
0,368  0,014  Male reproductive disfunction treatment
0,359  0,005  CDC-like kinase 1 inhibitor
0,382  0,042  Analeptic
0,360  0,020  GST M1-1 substrate
0,369  0,031  Antidiabetic symptomatic
0,347  0,014  Cholinergic
0,339  0,006  Alpha 2 adrenoreceptor antagonist
0,359  0,027  Antihypertriglyceridemic
0,371  0,040  Cytotoxic
0,336  0,006  Nitric-oxide synthase stimulant
0,350  0,029  Antineoplastic (lymphocytic leukemia)
0,321  0,006  Topoisomerase II alpha inhibitor
0,346  0,037  Mutagenic
0,312  0,003  CDC-like kinase 3 inhibitor
0,320  0,011  Acetylcholinesterase inhibitor
0,342  0,041  Proliferative diseases treatment
0,334  0,033  Sigma receptor agonist
0,383  0,084  TNF expression inhibitor
0,303  0,006  Alpha 2c adrenoreceptor antagonist
0,307  0,012  Antineoplastic (bone cancer)
0,391  0,096  Cyclophilin D inhibitor
0,391  0,096  Antidiabetic
0,308  0,014  Bipolar disorder treatment
0,343  0,052  CYP2D6 inhibitor
0,321  0,031  Abortion inducer
0,302  0,013  Antidiarrheal
0,300  0,017  Antiparkinsonian, tremor relieving
0,349  0,078  CYP3A4 substrate
0,316  0,048  Hypoglycemic
0,275  0,008  5 Hydroxytryptamine 3E antagonist
0,307  0,048  Antineoplastic (liver cancer)
0,307  0,049  Cardiovascular analeptic
0,277  0,019  CNS active muscle relaxant
0,313  0,063  CYP1A2 substrate
0,314  0,065  Lipoxygenase inhibitor
0,347  0,104  Antibacterial
0,307  0,068  Spasmolytic
0,256  0,019  LDLR expression enhancer
0,240  0,004  Estrogen receptor beta agonist
0,290  0,055  Cardiodepressant
0,257  0,026  Amylase inhibitor
0,245  0,014  Carcinogenic, group 2B
0,322  0,092  Stroke treatment
0,241  0,011  Microtubule formation inhibitor
0,252  0,024  Erectile dysfunction treatment
0,229  0,004  Endothelin receptor antagonist
0,240  0,018  DNA intercalator
0,281  0,058  Antiamyloidogenic
0,324  0,107  Antiprotozoal
0,316  0,102  GST A substrate
0,279  0,066  Antiprotozoal (Trypanosoma)
0,216  0,005  Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor
0,219  0,012  Alpha 2a adrenoreceptor antagonist
0,210  0,003  Endothelin B receptor antagonist
0,224  0,024  Antifungal enhancer
0,260  0,060  Antineoplastic (sarcoma)
0,251  0,054  Clk dual-specificity kinase inhibitor
0,206  0,012  Antineoplastic alkaloid
0,197  0,003  Endothelin A receptor antagonist
0,202  0,009  Estrogen receptor beta antagonist
0,266  0,075  CYP1A2 inhibitor
0,269  0,082  Antihypoxic
0,211  0,025  Antiviral (Hepatitis B)
0,216  0,035  Dual specificity tyrosine-phosphorylation regulated kinase 1B inhibitor
0,229  0,049  P-glycoprotein inhibitor
0,184  0,006  Acetylcholine M3 receptor agonist
0,207  0,031  Phobic disorders treatment
0,211  0,038  Cystic fibrosis treatment
0,179  0,006  Phosphodiesterase XI inhibitor
0,179  0,006  Phosphodiesterase 11A inhibitor
0,180  0,007  Alpha tubulin antagonist
0,187  0,015  Estrogen antagonist
0,192  0,019  Beta amyloid protein antagonist
0,238  0,066  Antiparasitic
0,258  0,093  Hypoxia-inducible factor 1 alpha inhibitor
0,213  0,049  Prostatic (benign) hyperplasia treatment
0,225  0,061  Anesthetic general
0,185  0,025  Cyclooxygenase 3 inhibitor
0,236  0,077  DNA synthesis inhibitor
0,159  0,005  Kinesin antagonist
0,159  0,005  Kinesin-like protein 1 inhibitor
0,243  0,088  5 Hydroxytryptamine uptake stimulant
0,246  0,093  Antiosteoporotic
0,170  0,020  Papain-like protease (SARS coronavirus) inhibitor
0,196  0,051  Liver fibrosis treatment
0,254  0,111  Bone diseases treatment
0,247  0,107  CYP2D6 substrate
0,208  0,068  Sedative
0,141  0,003  Glutamate (mGluR7) antagonist
0,158  0,020  Calcium antagonist
0,142  0,005  Topoisomerase II beta inhibitor
0,197  0,062  Antiviral (Hepatitis)
0,165  0,031  Pregnane X receptor agonist
0,168  0,034  Antibacterial (Helicobacter pylori)
0,298  0,167  5 Hydroxytryptamine release inhibitor
0,144  0,013  Restless leg syndrome treatment
0,146  0,016  Dopamine D3 antagonist
0,142  0,012  Phosphodiesterase 6D inhibitor
0,183  0,054  ATPase inhibitor
0,198  0,070  Carcinogenic
0,147  0,019  GST T1-1 substrate
0,166  0,038  MAP kinase kinase 4 inhibitor
0,184  0,058  Antianorexic
0,150  0,024  Beta glucuronidase inhibitor
0,166  0,040  Adenylate cyclase stimulant
0,177  0,052  NOS3 expression enhancer
0,192  0,067  Antipruritic, non-allergic
0,129  0,006  Estrogen receptor alpha agonist
0,248  0,126  Cholesterol antagonist
0,192  0,071  Antihelmintic
0,228  0,108  Radiosensitizer
0,215  0,098  Vascular (periferal) disease treatment
0,195  0,078  Insulin sensitizer
0,142  0,026  DOPA decarboxylase inhibitor
0,145  0,032  Antiviral (Influenza B)
0,126  0,015  mTOR complex 2 inhibitor
0,152  0,042  Acetylcholine muscarinic antagonist
0,188  0,078  CYP2B6 inhibitor
0,130  0,021  Inducible nitric-oxide synthase inhibitor
0,154  0,045  Alkylator
0,144  0,038  Alcohol dehydrogenase substrate
0,150  0,044  Ca2+-transporting ATPase inhibitor
0,145  0,040  5-Lipoxygenase inhibitor
0,110  0,005  Alpha-mannosidase inhibitor
0,216  0,111  Lipoprotein disorders treatment
0,187  0,082  UGT1A1 substrate
0,122  0,018  ATPase (Vacuolar H+) inhibitor
0,155  0,051  Skin whitener
0,127  0,023  Macrophage migration inhibitory factor inhibitor
0,144  0,042  Alpha 2b adrenoreceptor antagonist
0,162  0,061  UGT2B15 substrate
0,120  0,019  Phosphodiesterase V inhibitor
0,166  0,066  Uterine stimulant
0,249  0,151  CYP2C9 substrate
0,176  0,081  CDC-like kinase 4 inhibitor
0,105  0,010  Antiviral (Parainfluenza)
0,109  0,016  Postmenopausal disorders treatment
0,253  0,160  Antipruritic, allergic
0,221  0,129  12-Lipoxygenase inhibitor
0,111  0,019  Beta tubulin antagonist
0,134  0,042  Alpha adrenoreceptor antagonist
0,141  0,050  Skin irritative effect
0,137  0,046  Glutathione S-transferase substrate
0,226  0,136  CTGF expression inhibitor
0,103  0,014  Antitreponemal
0,117  0,028  Ornithine decarboxylase inhibitor
0,109  0,022  Dopamine D1 antagonist
0,141  0,055  Antihemorrhagic
0,170  0,084  Antirickettsial
0,161  0,076  Arachidonic acid antagonist
0,092  0,007  Mannosidase inhibitor
0,109  0,026  Keratolytic
0,108  0,025  Alpha adrenoreceptor agonist
0,136  0,054  Antitussive
0,103  0,022  Premenstrual syndrome treatment
0,161  0,081  UGT2B7 substrate
0,177  0,097  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,130  0,051  Cystathionine beta-synthase inhibitor
0,113  0,036  Actinic keratosis treatment
0,184  0,106  Hypolipemic
0,105  0,028  Glycine receptor antagonist
0,097  0,023  Female sexual dysfunction treatment
0,134  0,060  Acetylcholine antagonist
0,135  0,061  Cholinergic antagonist
0,078  0,004  Sodium/glucose cotransporter 2 inhibitor
0,131  0,058  Antiviral (Papilloma)
0,222  0,150  Antineoplastic (osteosarcoma)
0,093  0,021  Adrenaline uptake inhibitor
0,076  0,005  Melatonin 1 agonist
0,131  0,060  Antineoplastic (uterine cancer)
0,128  0,058  DNA repair enzyme inhibitor
0,122  0,052  Mucolytic
0,078  0,009  Adenylate cyclase 1 inhibitor
0,142  0,074  SULT1A3 substrate
0,096  0,028  Phosphodiesterase 5A inhibitor
0,144  0,077  Antiischemic, cerebral
0,100  0,034  Antiviral (Hepatitis A)
0,097  0,033  Histidine decarboxylase inhibitor
0,151  0,088  Mcl-1 antagonist
0,145  0,082  Antiviral (Herpes)
0,088  0,025  Acetylcholine M2 receptor antagonist
0,090  0,028  Phosphodiesterase VI inhibitor
0,178  0,117  UGT1A6 substrate
0,093  0,034  Glutamate decarboxylase inhibitor
0,082  0,023  Alpha 1 adrenoreceptor agonist
0,153  0,094  UGT2B10 substrate
0,184  0,125  RNA-directed DNA polymerase inhibitor
0,117  0,060  Sphingosine 1-phosphate receptor 2 agonist
0,157  0,100  Succinate dehydrogenase inhibitor
0,091  0,034  Estrogen receptor alpha antagonist
0,073  0,017  Acetylcholine M2 receptor agonist
0,085  0,030  Acetylcholine M5 receptor agonist
0,070  0,018  Ryanodine receptor antagonist
0,090  0,041  Thioredoxin reductase inhibitor
0,077  0,028  Neuraminidase inhibitor
0,193  0,145  Anxiolytic
0,053  0,005  Sodium/glucose cotransporter inhibitor
0,089  0,041  Nicotinic alpha4beta2 receptor antagonist
0,112  0,064  Activin receptor-like kinase 4 inhibitor
0,077  0,030  Exportin-1 inhibitor
0,190  0,143  UGT1A9 substrate
0,082  0,036  Glycine receptor agonist
0,180  0,136  Antihypotensive
0,164  0,119  Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor
0,128  0,085  Protein kinase stimulant
0,059  0,016  Microtubule stabilization
0,055  0,013  Phosphodiesterase 6C inhibitor
0,078  0,036  Glucagon-like peptide 1 agonist
0,086  0,045  Na+ K+ transporting ATPase inhibitor
0,102  0,061  Butyrylcholinesterase inhibitor
0,153  0,112  Pyruvate kinase inhibitor
0,045  0,004  Imidazoline I1 receptor antagonist
0,085  0,045  Dopamine antagonist
0,053  0,014  Glucocorticoid antagonist
0,132  0,093  Acetylcholine M1 receptor antagonist
0,192  0,153  UGT2B4 substrate
0,070  0,032  Alpha 2 adrenoreceptor agonist
0,132  0,094  Heat shock protein 90 antagonist
0,058  0,020  Factor III inhibitor
0,260  0,222  MAP kinase 1 inhibitor
0,158  0,121  Proto-oncogene tyrosine-protein kinase Fyn inhibitor
0,072  0,035  Glutamate (mGluR6) antagonist
0,080  0,043  GABA B receptor agonist
0,090  0,053  5 Hydroxytryptamine 2A antagonist
0,053  0,017  Dopamine D3 agonist
0,091  0,056  Antidote, mercury
0,102  0,067  AMP-activated protein kinase stimulant
0,117  0,083  Antismoking
0,092  0,058  Paget's disease treatment
0,186  0,153  Antiepileptic
0,133  0,099  UGT2B9 substrate
0,131  0,098  Eye irritation, high
0,073  0,041  Anticholelithogenic
0,077  0,046  Lipase inhibitor
0,041  0,010  Phosphodiesterase 6B inhibitor
0,111  0,080  MAO inhibitor
0,183  0,153  CYP2C19 substrate
0,115  0,085  Cyclooxygenase 1 inhibitor
0,071  0,042  Endocannabinoid uptake inhibitor
0,093  0,064  Alpha 2d adrenoreceptor antagonist
0,131  0,103  Raynaud's phenomenon treatment
0,063  0,035  Heat shock protein 90 beta antagonist
0,035  0,008  Sodium/glucose cotransporter 1 inhibitor
0,083  0,057  Antiprotozoal activity enhancer
0,182  0,156  Antidiabetic (type 2)
0,049  0,023  Glutamate (mGluR group III) antagonist
0,112  0,086  Alpha-N-acetylglucosaminidase inhibitor
0,040  0,015  Melatonin agonist
0,190  0,164  Gastrin inhibitor
0,147  0,121  Embryotoxic
0,109  0,084  Antiseptic
0,189  0,164  NOS3 expression inhibitor
0,106  0,081  Carcinogenic, group 3
0,181  0,158  Renal disease treatment
0,071  0,048  Secretase beta inhibitor
0,025  0,003  Imidazoline I2 receptor antagonist
0,153  0,133  Dyrk kinase inhibitor
0,059  0,039  Dopamine uptake inhibitor
0,029  0,009  Phosphodiesterase 6H inhibitor
0,029  0,009  Phosphodiesterase 6G inhibitor
0,095  0,075  Expectorant
0,063  0,044  Nitric oxide donor
0,083  0,064  Transcription factor NF kappa B stimulant
0,057  0,039  Postcoital contraceptive
0,111  0,092  Phosphodiesterase inhibitor
0,119  0,101  Cell wall synthesis inhibitor
0,087  0,069  MAO B inhibitor
0,043  0,025  Plasmepsin II inhibitor
0,077  0,059  Antineoplastic antibiotic
0,050  0,033  HCV NS3/NS4A protease inhibitor
0,131  0,114  Heat shock protein 70 antagonist
0,059  0,042  Aromatase inhibitor
0,093  0,077  5 Hydroxytryptamine 2 antagonist
0,051  0,035  Anesthetic inhalation
0,083  0,069  Antiadrenergic
0,146  0,134  Anticonvulsant
0,080  0,068  Adrenaline antagonist
0,041  0,029  Hypogonadism treatment
0,209  0,198  Antiobesity
0,089  0,078  UGT2B11 substrate
0,060  0,050  Dopamine D2 antagonist
0,204  0,193  FMO1 substrate
0,202  0,193  Antiprotozoal (Plasmodium)
0,087  0,078  UDP-glucose 4-epimerase inhibitor
0,023  0,015  Isoleucine-tRNA ligase inhibitor
0,084  0,076  Obsessive-compulsive disorder treatment
0,202  0,195  Immunosuppressant
0,065  0,059  SULT2A1 substrate
0,043  0,038  Potassium channel Kv1.3 blocker
0,045  0,039  Glucose-6-phosphate isomerase inhibitor
0,091  0,086  Excitatory amino acid transporter EAAC1 inhibitor
0,022  0,017  Prostaglandin F2 alpha agonist
0,120  0,116  Thiol protease inhibitor
0,084  0,081  Creatine kinase inhibitor
0,066  0,063  Acetylcholine M4 receptor antagonist
0,090  0,087  UGT2B1 substrate
0,089  0,087  HDL-cholesterol increasing
0,083  0,081  Antiviral (Rhinovirus)
0,086  0,085  Nitric-oxide synthase inhibitor
0,014  0,013  Thromboxane A2 agonist
0,134  0,133  3C-like protease (Human coronavirus) inhibitor
0,124  0,124  MAP kinase 3 inhibitor

